BenevevolentAI is a global pioneer and leader in AI-augmented drug discovery. We serve patients by leveraging our proprietary and validated Benevolent Platform that integrates AI and science to uncover new biology, predict novel targets and develop first-in-class or best-in-class drugs for complex diseases. By applying proprietary advanced AI tools, in combination with in-house scientific expertise and wet-lab facilities, Benevolent is well-positioned to identify and accelerate novel drug discoveries.
View Top Employees from BenevolentAIWebsite | http://benevolent.com |
Revenue | $21 million |
Funding | $115 million |
Employees | 412 (412 on RocketReach) |
Founded | 2013 |
Phone | +44 20 3781 9360 |
Technologies |
JavaScript,
HTML,
PHP
+24 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Business Services General, Drug Discovery, Artificial Intelligence, Business Services, Science and Engineering, Drug Development, Nutraceutical, Health Care |
Web Rank | 1 Million |
Keywords | Benevolentai, Benevolent Ai, Benevolent Tech, Bioinformatics Chemoinformatics Startup, Benevolentai Janssen |
SIC | SIC Code 73 Companies, SIC Code 737 Companies, SIC Code 7372 Companies |
NAICS | NAICS Code 511210 Companies, NAICS Code 511 Companies, NAICS Code 5112 Companies, NAICS Code 51121 Companies, NAICS Code 51 Companies |
Looking for a particular BenevolentAI employee's phone or email?
The BenevolentAI annual revenue was $21 million in 2024.
Dan Neil is the CTO of BenevolentAI.
412 people are employed at BenevolentAI.
The NAICS codes for BenevolentAI are [511210, 511, 5112, 51121, 51].
The SIC codes for BenevolentAI are [73, 737, 7372].